FDA 510(k)

Xerosyn

N.º K: K233259 · 2024-06-21

Fecha de decisión2024-06-21

Código de productoMQV

Comité asesorOR

DecisiónSubstantially Equivalent

Resumen del dispositivo

Xerosyn is the device name listed in this FDA 510(k) record. The listed applicant is Xerothera, Inc.. It received FDA 510(k) clearance on 2024-06-21 under 510(k) number K233259. The device is classified under product code MQV. It was reviewed by the OR advisory panel. FDA Decision: Substantially Equivalent.

Preguntas frecuentes

What is the Xerosyn?

Xerosyn is a medical device that received FDA 510(k) clearance on 2024-06-21. The listed applicant is Xerothera, Inc.. The 510(k) number is K233259.

When did Xerosyn receive FDA 510(k) clearance?

Xerosyn received FDA 510(k) clearance on 2024-06-21, under 510(k) number K233259.

Who is the listed applicant for Xerosyn?

The FDA 510(k) record lists Xerothera, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Xerosyn?

The FDA product code for Xerosyn is MQV.

Ensayos clínicos relacionados

Los registros relacionados se emparejan automáticamente mediante nombres, códigos de producto u otros metadatos. Un emparejamiento no establece una relación clínica, científica, corporativa o regulatoria verificada; revise las fuentes oficiales enlazadas.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITING NCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITING NCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDED NCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Dispositivos relacionados (Código: MQV)

Fuente oficial

Ver en la base de datos de la FDA →

Datos procedentes de la API abierta de la FDA. Para obtener la información más actualizada y autoritativa, consulte siempre el registro oficial.